AML |
acute myeloid leukemia |
EMI |
extramedullary infiltration |
EMD |
extramedullary disease |
TARGET |
Therapeutically Applicable Research to Generate Effective
Treatments |
CNS |
central nervous system |
MS |
myeloid sarcoma |
GO |
gemtuzumab ozogamicin |
IT |
intrathecal |
WBC |
white blood cell |
BM |
bone marrow |
PB |
peripheral blood |
FAB |
French-American-British classification |
SCT |
stem cell transplantation |
CR |
complete remission |
MRD |
minimal residual disease |
OS |
overall survival |
EFS |
event-free survival |
RFS |
relapse-free survival |
HR |
hazards ratio |
CI |
confidence interval |